- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06171737
Promoting Shared Decision Making for Severe Aortic Stenosis (IMPACT SDM)
PCORI-CDR-2022C1-26333 Promoting Shared Decision Making for Decisions About Treatment of Severe Aortic Stenosis (IMPACT SDM Study)
The goal of this study is to increase shared decision making for patients considering treatment for severe aortic stenosis. The main questions it aims to answer are:
- Do patient decision aids and clinician skills training course improve the quality of decisions, and do they work well for different patient populations?
- Are heart clinics able to reach the majority of patients with decision aids before their specialist visit and do the majority of clinicians complete the training course?
All participating sites will start in the usual care group and then will be randomly assigned a time to switch to the intervention group. Participants will complete surveys before and after their specialist visit.
Researchers will compare data from patients seen during usual care with data from those seen after the interventions are implemented to see if there are improvements in the quality of decisions.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The goal of this study is to promote shared decision making for patients considering treatment for severe aortic stenosis. The main questions it aims to answer are:
- Do patient decision aids and clinician skills training course improve the quality of decisions, and do they work well for different patient populations?
- Are heart clinics able to reach the majority of patients with decision aids before their specialist visit and do the majority of clinicians complete the training course?
This study is a stepped wedge cluster randomized trial with 8 sites, about 56 surgeons and interventional cardiologists, and will enroll about 1400 patients. All participating sites will start in the usual care group and then will be randomly assigned a time to switch to the intervention group. The interventions include a patient decision aid that was created by the American College of Cardiology CardioSmart program and a online shared decision making skills training course for clinicians. The coordinating center will provide implementation support to sites when they transition to the intervention arm. Data collection is similar across usual care and intervention groups. Patient participants will complete surveys before and after their specialist visit. Clinician participants will be randomly selected to complete a survey after the patient visit. Limited clinical data will be collected from the medical record.
Researchers will compare data from patients seen during usual care with data from those seen after the interventions are implemented to see if there are improvements in the quality of decisions. Researchers will also calculate percentage of patients reached with decision aids and percentage of clinicians who complete training at each site to measure the success of the implementation.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karen Sepucha, PhD
- Phone Number: 617-724-3350
- Email: ksepucha@partners.org
Study Contact Backup
- Name: KD Valentine, PhD
- Phone Number: 617-724-1621
- Email: kvalentine2@mgh.harvard.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94117
- The Regents of the University of California, San Francisco
-
Contact:
- Sammy Elmariah
- Email: Sammy.Elmariah@ucsf.edu
-
-
Colorado
-
Aurora, Colorado, United States, 80045-7202
- University of Colorado Denver
-
Contact:
- Christopher Knoepke
- Phone Number: 303-724-9938
- Email: christopher.knoepke@cuanschutz.edu
-
Contact:
- Daniel Matlock
- Phone Number: 303.724.9941
- Email: daniel.matlock@cuanschutz.edu
-
-
Georgia
-
Atlanta, Georgia, United States, 30308-0000
- Emory University
-
Contact:
- Chandan Devireddy
- Phone Number: 404-686-2513
- Email: cdevire@emory.edu
-
Contact:
- Neal Dickert
- Phone Number: 404-712-6834
- Email: njr@emory.edu
-
Atlanta, Georgia, United States, 30309-1285
- Piedmont Healthcare
-
Contact:
- Vinod Thourani
- Email: Vinod.Thourani@piedmont.org
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599-1350
- The University of North Carolina at Chapel Hill
-
Contact:
- Matthew Cavender
- Phone Number: 919-843-1507
- Email: matt.cavender@unc.edu
-
-
Oregon
-
Portland, Oregon, United States, 97225
- Providence Health & Services - Oregon
-
Contact:
- Ethan Korngold
- Phone Number: 503-216-0790
- Email: Ethan.korngold@providence.org
-
-
Texas
-
Dallas, Texas, United States, 75390-9020
- UT Southwestern Medical Center
-
Contact:
- Dharam Kumbhani
- Email: dharam.kumbhani@utsouthwestern.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Between 65-85 years of age
- Language is English or Spanish
- Diagnosed with severe aortic stenosis (aortic valve area <1cm2)
- Attend Visit with Heart Valve Team physician(s)
Exclusion Criteria:
- Prior aortic valve replacement surgery
- High surgical risk (determined by clinician or defined as Society of Thoracic Surgery score >8%)
- Prior coronary artery bypass surgery (CABG)
- End stage renal disease on dialysis
- Severe lung disease (chronic obstructive pulmonary disease; COPD) requiring home oxygen
- Advanced Cirrhosis
- Unable to consent for self (proxy respondents are not allowed)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control (usual care)
This group will receive usual care without any support for using the decision aid and without any access to the clinician training.
|
|
Active Comparator: Intervention
The patients in this group will receive a decision aid that covers the main treatment options for aortic stenosis. The clinicians in this group will receive a 60-minute online training session that will provide practical tips, interactive case studies and tools for conducting shared decision making conversations covering core competencies |
The American College of Cardiology decision aid: Treatment Options for Severe Aortic Stenosis for patients deciding between Tavi and Surgery
60-minute online training session that will provide practical tips, interactive case studies and tools for conducting shared decision making conversations covering core competencies
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Shared Decision Making
Time Frame: About 1 week post visit
|
Shared Decision Making Process scale; Scores range 0-4 with higher scores indicating greater shared decision making occurred.
|
About 1 week post visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reach
Time Frame: About 1 week post visit
|
% of eligible patients who receive decision aid
|
About 1 week post visit
|
Patient Knowledge
Time Frame: About 1 week post visit
|
Multiple choice knowledge score ranging from 0-100; higher scores indicate higher knowledge
|
About 1 week post visit
|
Preference-treatment concordance
Time Frame: About 1 week post visit
|
% of patients who received preferred treatment within 6 months of visit
|
About 1 week post visit
|
Patient experience
Time Frame: About 1 week post visit
|
CAHPS MD-patient communication subscale and visit rating score
|
About 1 week post visit
|
Clinician satisfaction
Time Frame: About 1 week post visit
|
% of clinicians who mark "very" or "extremely" satisfied with visit
|
About 1 week post visit
|
Adoption
Time Frame: 4 weeks from the start of intervention period for each site
|
% of eligible clinicians who complete the shared decision making skills training
|
4 weeks from the start of intervention period for each site
|
Timeliness (time to decision)
Time Frame: About 1 week post visit
|
% of patients who report stage of decision making is "made a decision"
|
About 1 week post visit
|
Timeliness (burden)
Time Frame: About 1 week post visit
|
% of visits where clinicians report visit length is "longer than normal"
|
About 1 week post visit
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Karen Sepucha, PhD, Massachusetts General Hospital
- Principal Investigator: Sammy Elmariah, MD, University of California, San Francisco
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023P001413
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Stenosis
-
Abbott Medical DevicesActive, not recruitingSevere Aortic Stenosis | Symptomatic Degenerative Aortic StenosisSpain, Italy, United Kingdom, Germany, Switzerland, Czechia, Australia, Belgium, Poland
-
Hospices Civils de LyonRecruiting
-
Edwards LifesciencesActive, not recruitingAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Anteris Technologies Ltd.Active, not recruitingAortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisGeorgia
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
Edwards LifesciencesCompletedAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Ningbo Jenscare Biotechnology Co., Ltd.UnknownAortic Regurgitation | Severe Aortic Stenosis
-
Genesis Medtech CorporationRecruitingDiseases of Aortic Valve | Aortic Stenosis DiseaseChina
-
Saint Petersburg State University, RussiaNot yet recruitingIschemic Heart Disease | Mitral Insufficiency | Aortic Stenosis, Severe | Mitral Stenosis | Aortic Insufficiency | Ascending Aortic Aneurysm | Mitral Stenosis With Insufficiency | Tricuspid InsufficiencyRussian Federation
-
Pan XiangbinRecruiting
Clinical Trials on Decision Aid
-
University of LeedsBaxter Healthcare Corporation; National Health Service, United Kingdom; Foundation... and other collaboratorsCompletedChronic Kidney FailureUnited Kingdom
-
Massachusetts General HospitalCompletedCoronary Artery Disease | Stable AnginaUnited States
-
University Hospital HeidelbergInnovationsfonds des Gemeinsamen Bundesausschusses, GermanyCompletedPatient Decision Aid | Treatment As UsualGermany
-
Case Comprehensive Cancer CenterCompletedProstate CancerUnited States
-
Duke UniversityFoundation for Informed Medical Decision MakingCompletedOsteoarthritisUnited States
-
Massachusetts General HospitalUnknownDecision Making | Video Decision AidsUnited States
-
Kaiser PermanenteFoundation for Informed Medical Decision MakingCompletedObesity | Obesity, Morbid | Bariatric Surgery | Decision AidsUnited States
-
University of UtahPatient-Centered Outcomes Research Institute; Mayo Clinic; Northwestern University and other collaboratorsActive, not recruitingAtrial FibrillationUnited States
-
University of MichiganNational Cancer Institute (NCI)Completed
-
Massachusetts General HospitalCompleted